|Titre :||Study to obtain comparable national estimates of problem drug use prevalence for all EU member states. Final report. EMCDDA project CT.97.EP.04|
|Auteurs :||L. KRAUS ; R. AUGUSTIN ; P. KÜMMLER ; L. WIESSING ; R. HARTNOLL|
|Type de document :||Rapport|
|Mention d'édition :||CT.97.EP.04|
|Editeur :||München : IFT, 1999|
|Format :||61 p.|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASEPREVALENCE ; EPIDEMIOLOGIE DESCRIPTIVE ; COMPARAISON ; METHODE
The project CT.97.EP.04 to improve comparability of national prevalence estimates of addiction in all EU member states including Norway is a follow-up study of the pilot project CT.96.EP.06 (EMCDDA 1997a). The project CT.97.EP.04 extends the methods recommended by the pilot work group to estimate prevalence of problem drug use in all EU member states.
In order to attain comparable estimates of the extent of problem drug use in different countries, the same methods, equivalent data sources, and as a consequence, the same definition of problem drug use in all countries was used. In accordance with the local estimation prevalence project (EMCDDA 1997b), problem drug use was defined as intravenous drug use (IDU) or long duration/regular use of opiates, cocaine and/or amphetamines. Ecstasy and cannabis were not included. Due to differences in demographic structures, it was also necessary to use the same age group when prevalence rates, i.e., prevalence per 1000 inhabitants, were compared. It was agreed upon to provide prevalence estimates for the age group 15-54.
The following methods were used in the project:
- The demographic method
- The multiplier method with the data sources
- Treatment data
- Police data
- Mortality data
- Capture-recapture method
- The multivariate indicator method
- Mathematical modelling of HIV/AIDS epidemic.
|Domaine :||Drogues illicites / Illicit drugs|
|Centre Emetteur :||13 OFDT|
Documents numériques (1)
Adobe Acrobat PDF